Eden Research plc (LON:EDEN – Get Free Report)’s stock price shot up 2.8% during mid-day trading on Tuesday after an insider bought additional shares in the company. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares traded hands during mid-day trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The firm’s 50 day moving average price is GBX 3.88 and its two-hundred day moving average price is GBX 4.01. The company has a debt-to-equity ratio of 1.25, a quick ratio of 2.42 and a current ratio of 3.80. The firm has a market cap of £19.73 million, a PE ratio of -200.00 and a beta of 0.92.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Articles
- Five stocks we like better than Eden Research
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What Are Earnings Reports?
- What Does the Future Hold for Eli Lilly?
- What is Insider Trading? What You Can Learn from Insider Trading
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.